Perspective
Dec. 19, 2012
Securities fraud case could impact settlement strategies
What must securities fraud plaintiffs prove at the class certification stage? The answer will have far reaching consequences due to certification's unique ability to drive settlement negotiations. By Joshua Hill and Jonathan Feingold
The U.S. Supreme Court recently heard argument in Amgen Inc. v. Connecticut Retirement Plans and Trust Funds, in which Amgen argued that securities fraud plaintiffs should be required to demonstrate the materiality of alleged misrepresentations as a prerequisite to class certification under the fraud-on-the-market theory. Although the questions posed by Amgen are formally limited to a plaintif...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
